Floatz logo

METOPROLOL

CP-B Liver Cirrhosis

Boehringer IngelheimSmall moleculePhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the CP-B Liver Cirrhosis cohort.

Asset / SponsorPhaseRating
Sorafenib
National Cancer Institute (NCI)
Phase 2B
CAFFEINE
Boehringer Ingelheim
Phase 2CCC
Omeprazole
Boehringer Ingelheim
Phase 2CCC

Same molecule, other indications

METOPROLOL is also rated in:

cardiomyopathyDormant
B
Indicative ·
60 / 100
View asset →
heart disorderDormant
B
Indicative ·
60 / 100
View asset →
beta thalassemiaDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →